Tuberculosis News and Research

Latest Tuberculosis News and Research

ERS collaborates with 3D Systems to provide simulation equipment for EBUS training centers

The European Respiratory Society and 3D Systems have signed a collaboration agreement to provide simulation equipment and event services for training centers for use in the ERS Endobronchial Ultrasound Certified Training Program.

3 Aug 2018

Otsuka’s JINARC approved for treatment of patients with CKD stage 4 ADPKD

Otsuka Pharmaceutical Europe Ltd. today announced that the European Commission has approved an extension of indication for JINARC to include adult patients with CKD stage 4 Autosomal Dominant Polycystic Kidney Disease

2 Aug 2018

Co-Diagnostics obtains CE mark approval for Logix Smart MTB Test

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, proprietary platform for the development of molecular diagnostic tests, announced today that its Logix Smart™ MTB Test has obtained CE mark approval, the principle regulatory clearance allowing the test to be sold as an in vitro diagnostic for the diagnosis of tuberculosis in European Union states and other markets that accept a CE-IVD mark as valid regulatory approval.

25 Jul 2018

Environment could be important battle ground in the global fight against antibiotic resistance

The environment could be as important a battle ground as the clinic in the global fight against the spread of antibiotic resistance, new research has shown.

24 Jul 2018

California clinic screens asylum seekers for honesty

Dr. Nick Nelson walks through busy Highland Hospital to a sixth-floor exam room, where he sees patients from around the world who say they have fled torture and violence.

16 Jul 2018

Retooled vaccine raises hopes as a lower-cost treatment for Type 1 diabetes

For Hodalis Gaytan, 20, living with Type 1 diabetes means depending on an assortment of expensive medicines and devices to stay healthy. Test strips. Needles. A glucose meter. Insulin.

13 Jul 2018

Aeras announces publication of Phase 2 results of two TB vaccines

Aeras, a nonprofit organization dedicated to developing vaccines against tuberculosis (TB), today announced the publication of the full results from a Phase 2, randomized, controlled clinical trial of two TB vaccines-- the currently available BCG vaccine and an investigational vaccine, H4:IC31--in the New England Journal of Medicine (NEJM).

12 Jul 2018

Molecular insights of NagA enzyme could help combat TB

Research by a team led by Dr Elizabeth Fullam, has revealed new findings about an enzyme found in Mycobacterium tuberculosis the bacterium that causes TB.

12 Jul 2018

Study reveals how M. tuberculosis escapes death in macrophages

The bacteria that cause the devastating disease tuberculosis have the ability to escape destruction and grow after they are engulfed by lung macrophages, the immune cells that are supposed to destroy pathogens.

10 Jul 2018

Bacteria adapted to the human body may become more susceptible to antibiotics

A new study published today in Nature Communications, led by scientists at the University of Liverpool in collaboration with the University of Salford, finds evidence that as bacteria adapt to the human body, they can sometimes become more susceptible to antibiotics and therefore easier to kill.

6 Jul 2018

Higher doses of rifampin kill more TB bacteria in sputum without increasing adverse effects

Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

29 Jun 2018

Water-limited landscapes can facilitate disease transmission

In water-limited landscapes sick animals can have increased contact with healthy individuals, which can facilitate disease transmission. Scientists from the German Leibniz Institute for Zoo and Wildlife Research present these findings in the British Ecological Society journal Functional Ecology.

20 Jun 2018

Gene signature could improve early diagnosis of TB

Researchers have identified a gene signature that could determine whether a person is going to develop TB, months before they show any symptoms.

19 Jun 2018

If you’ve got hep C, spitting can be a felony

Last week, an Ohio man who has the hepatitis C virus was sentenced to 18 months in prison for spitting at Cleveland police and medics.

19 Jun 2018

WVU researcher aims to produce updated whooping cough vaccine

Before the whooping-cough vaccine came into widespread use in the 1940s, about 9,000 American children died from the infection each year. Today, thanks to the vaccine's efficacy, reported cases of whooping cough have dramatically declined and fatalities have dropped to up to 20 children each year.

18 Jun 2018